iAwards Program Call for Pre-Proposals: Deadline September 7, 2018
We are pleased to announce the fourth annual call for pre-proposals for the Sanofi iAwards Program, which supports research ideas early in the translational path at the transition between basic research and first proof of concept.
The iAwards program provides $125,000 in research funding for a one-year study, and successful projects have the potential to grow into sponsored research agreements with significantly increased funding and timelines. Over the past 3 years, 17 projects have been funded at BWH and MGH across a diverse range of therapeutic areas.
Research areas of interest: immune-oncology, molecular oncology, immunology & inflammation, rare diseases, neurosciences, diabetes and cardiovascular diseases. In addition, pre-proposals in technology areas including gene therapy, single-cell analysis and biologics development will also be considered.
Please see attached flyer for detailed research areas of interest and further information.
Funding & Term: $125,000 (total amount including indirect costs) over one year.
- Please use the attached template, and limit your pre-proposal to two pages, excluding publications.
- Only the JSSC and select members of Sanofi and your Institution will have access to your preproposal. However, information in the pre-proposal is NOT considered confidential and therefore unpublished information should not be disclosed.
- No third-party collaborators, except for other iAward partner institutions (listed in the flyer), are permitted.
Submit your pre-proposal to firstname.lastname@example.org before September 7th, 2018.
Please reach out to Julian Peat at email@example.com for further information.
We look forward to working with you in submitting innovative, early-translation projects to be funded by the Sanofi iAwards Program!
Strategic Alliances Team, Partners Innovation